Predictive Oncology Net Profit Margin 2010-2025 | POAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.6B
Tempus AI (TEM)	$12.1B
Doximity (DOCS)	$12B
Hims & Hers Health (HIMS)	$10.8B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.5B
Inspire Medical Systems (INSP)	$2.6B
Privia Health (PRVA)	$2.6B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.7B
Azenta (AZTA)	$1.5B
Schrodinger (SDGR)	$1.5B
Omnicell (OMCL)	$1.4B
Clover Health Investments (CLOV)	$1.3B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$666M
Veradigm (MDRX)	$509M
Zepp Health (ZEPP)	$504M
Standard BioTools (LAB)	$498M
Talkspace (TALK)	$432M
Carlsmed (CARL)	$365M
Butterfly Network (BFLY)	$357M
TruBridge (TBRG)	$300M
Outset Medical (OM)	$235M
Health Catalyst (HCAT)	$227M
Nyxoah SA (NYXH)	$215M
SOPHiA GENETICS SA (SOPH)	$210M
KORU Medical Systems (KRMD)	$199M